Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) Gross Margin (2016 - 2025)

Bio Key International (BKYI) has disclosed Gross Margin for 16 consecutive years, with 76.9% as the latest value for Q3 2025.

  • Quarterly Gross Margin fell 141.0% to 76.9% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 78.4% through Sep 2025, up 1882.0% year-over-year, with the annual reading at 81.39% for FY2024, 6294.0% up from the prior year.
  • Gross Margin hit 76.9% in Q3 2025 for Bio Key International, up from 72.65% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 86.26% in Q1 2024 to a low of 5.23% in Q4 2023.
  • Historically, Gross Margin has averaged 61.01% across 5 years, with a median of 72.65% in 2025.
  • Biggest five-year swings in Gross Margin: crashed -5259bps in 2023 and later soared 8729bps in 2024.
  • Year by year, Gross Margin stood at 60.21% in 2021, then decreased by -27bps to 44.02% in 2022, then crashed by -112bps to 5.23% in 2023, then skyrocketed by 1668bps to 82.06% in 2024, then decreased by -6bps to 76.9% in 2025.
  • Business Quant data shows Gross Margin for BKYI at 76.9% in Q3 2025, 72.65% in Q2 2025, and 82.61% in Q1 2025.